Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial

JAMA Surgery
September 7, 2022
Cited by 22


Related Papers

No related papers found

Powered by citation graph analysis